Vermillion/Quest's OVA1 Ovarian Cancer Risk Test Cleared by FDA as IVDMIA

The IVDMIA is the first FDA-cleared test for ovarian cancer detection in the pre- and post-surgical setting and will be available for physician use in the fourth quarter.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.